| __timestamp | Sarepta Therapeutics, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 94231000 | 4101058 |
| Thursday, January 1, 2015 | 146394000 | 10763215 |
| Friday, January 1, 2016 | 188272000 | 5579049 |
| Sunday, January 1, 2017 | 166707000 | 32051299 |
| Monday, January 1, 2018 | 401843000 | 24482286 |
| Tuesday, January 1, 2019 | 560909000 | 43892589 |
| Wednesday, January 1, 2020 | 722343000 | 44505000 |
| Friday, January 1, 2021 | 771182000 | 79406000 |
| Saturday, January 1, 2022 | 877090000 | 49283000 |
| Sunday, January 1, 2023 | 877387000 | 17282730 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, Sarepta Therapeutics, Inc. and Verona Pharma plc have demonstrated contrasting strategies in their R&D expenditures.
Sarepta Therapeutics, a leader in genetic medicine, has consistently increased its R&D spending, peaking in 2023 with an investment nearly 10 times higher than its 2014 figures. This reflects a robust commitment to advancing therapies for rare diseases. In contrast, Verona Pharma, focusing on respiratory diseases, has shown a more modest growth in R&D spending, with a notable peak in 2021, marking a 93% increase from 2014.
These trends highlight the varying approaches within the biotech sector, where strategic R&D investments can significantly impact a company's innovation pipeline and market position.
Analyzing R&D Budgets: AbbVie Inc. vs Verona Pharma plc
R&D Spending Showdown: AstraZeneca PLC vs Sarepta Therapeutics, Inc.
GSK plc vs Sarepta Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Verona Pharma plc
Viatris Inc. or Verona Pharma plc: Who Invests More in Innovation?
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for Sarepta Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
R&D Spending Showdown: Sarepta Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Research and Development Investment: Sarepta Therapeutics, Inc. vs Dynavax Technologies Corporation
Analyzing R&D Budgets: Verona Pharma plc vs PTC Therapeutics, Inc.
R&D Spending Showdown: Verona Pharma plc vs Mesoblast Limited